StockData
Camp4 Therapeutics Corp logo

Camp4 Therapeutics Corp (CAMP) stock

CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.00+0.14 (+3.63%)

Close on Nov 17, 2026Market cap $251.01MP/E –Yield 0.00%

Camp4 Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Camp4 Therapeutics's price to book ratio was 5.8× on Jul 31, 2026, against 0.6× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20265.8×+0.9
2025Dec 31, 20254.9×–

More Camp4 Therapeutics figures

See a number that looks wrong?